Breye Therapeutics ApS
CVR: 40279865
Established (7 yrs)Loss-making
Secondary names: Ciana Therapeutics ApS
Active
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 13.2.2019
Details
- Capital
- 341.672 kr.
Contact
Advertising protectedPurpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
Location
Financials
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -7.5 mio. | -89.1 mio. | 57 mio. | -40.6 mio. | 3 | |
History
Ownership
Owners
Novo Holdings A/S
CVR: 24257630
33,33-49,99%
Visus Holding ApS
CVR: 40279113
10-14,99%
BII Holdings A/S
CVR: 41059850
5-9,99%
Breye Therapeutics ApS
CVR: 40279865
Management
Directors
Ulrik Mouritzen(ADM. DIR.)
Board
Jimmy Arnold V Van Heusden(FORMAND)
Carl Johan Kördel(BESTYRELSESMEDLEM)
Chiara Rossana Maria Liberati(BESTYRELSESMEDLEM)
Gabriela Burian(BESTYRELSESMEDLEM)
Jørgen Søberg Petersen(BESTYRELSESMEDLEM)
Ulrik Mouritzen(BESTYRELSESMEDLEM)
Founders
Production units (1)
Breye Therapeutics ApS
P-no: 1024431394
Agern Alle 24, 2970, Hørsholm
Fremstilling af farmaceutiske præparater
1 employees
Similar companies
Companies in the same industry and area